Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1Head & Neck 1

Conditions

Rectal Neoplasms 34Esophageal Neoplasms 19Pancreatic Neoplasms 9Esophageal Squamous Cell Carcinoma 6Stomach Neoplasms 4Colorectal Neoplasms 4Carcinoma, Squamous Cell 3Resectable Esophageal Cancer 2Pathologic Complete Response 2Neoplasms by Site 2Neoplasms 2Gallbladder Neoplasms 2Cholangiocarcinoma 2Carcinoma 2Adenocarcinoma Of Esophagus 2Adenocarcinoma 2Thrombocytopenia 1Rectal Malignant Neoplasms 1Rectal Diseases 1Radiation Injuries 1Postoperative Complications 1Patients With Esophageal Cancer(â…¡-â…¢) 1Pancreatic Cancer Non-resectable 1Neoplasms, Glandular and Epithelial 1Neoplasms, Cystic, Mucinous, and Serous 1Neoplasms by Histologic Type 1Margins of Excision 1Lymphatic Metastasis 1Low Anterior Resection Syndrome 1Locally Advanced Rectal Cancer 1

Interventions

Gemcitabine 69pembrolizumab 44Fluorouracil 44Oxaliplatin 42Capecitabine 40Bevacizumab 37Leucovorin 36Irinotecan 31Cisplatin 28Nivolumab 24Paclitaxel 21Cetuximab 21Panitumumab 20130-nm albumin-bound paclitaxel 20Sorafenib 18Albumin-Bound Paclitaxel 18Drug Therapy 15Docetaxel 15Cyclophosphamide 15Radiotherapy 14Blood Specimen Collection 14IFL protocol 12atezolizumab 11Exercise 11Taxes 10budigalimab 9Erlotinib Hydrochloride 9Carboplatin 9trametinib 8Folfox protocol 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Chemoradiotherapy × Gastrointestinal × Clear all
NCT01037049 2018-09-17

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

Royal Marsden NHS Foundation Trust

Phase 2 Unknown
237 enrolled
Gastrointestinal

Adenocarcinoma, Carcinoma, Adenocarcinoma, Mucinous, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms, Neoplasms, Cystic, Mucinous, and Serous

NCT01507103 2017-01-13

SPRINT

Merck KGaA, Darmstadt, Germany

Phase 2 Completed
124 enrolled 9 charts
Gastrointestinal

Carcinoma, Neoplasms, Neoplasms by Site, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡